# Cognitive alterations related to driving performance in Parkinson’s disease detected by a driving simulator

**Authors:** Almudena Cerezo-Zarzuelo, Francisco José Sánchez-Cuesta, Carlota Trigo, Eduardo Rocon, Jorge Villagra, Juan Felipe Medina-Lee, Vinicius Trentin, Juan Pablo Romero

PMC · DOI: 10.1038/s41598-025-31585-y · 2025-12-09

## TL;DR

This study shows that driving simulators can detect early driving impairments in Parkinson’s disease patients before they appear on standard cognitive tests.

## Contribution

The study introduces the use of high-fidelity driving simulators to detect subtle driving impairments in early Parkinson’s disease.

## Key findings

- PD participants showed slower response times and reduced lane control during driving simulations.
- Driving difficulties were linked to disease severity and medication dosage.
- Driving simulators were more sensitive than standard tests in detecting early impairments.

## Abstract

Driving ability in individuals with Parkinson’s disease (PD) can be compromised early in the course of the illness, even before clear cognitive deficits emerge on standard neuropsychological tests. This study investigated subtle driving impairments in a group of non-demented people with PD using a high-fidelity driving simulator. Seven PD participants and seven healthy controls, matched for age and sex, completed cognitive assessments, reaction time tasks, and five simulated driving scenarios that measured lane keeping, steering control, and reaction to events. While most cognitive scores were comparable between groups, PD participants exhibited slower response times in basic tasks and showed reduced lane control, particularly during left turns. These difficulties were associated with disease severity and medication dosage. The simulator proved more sensitive than conventional tests in detecting early impairments related to attention and visuospatial processing. These findings suggest that driving simulators may play a key role in improving the assessment of driving competence in PD, providing insight into real-world challenges faced by this population.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Diseases:** Cognitive alterations (MESH:D003072), Parkinson's disease (MESH:D010300)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12804182/full.md

---
Source: https://tomesphere.com/paper/PMC12804182